Form 4 Tracker
John R Stuelpnagel

Director · 3 filings · Latest: Sep 3, 2026

10x Genomics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
TXG
John R StuelpnagelDirectorSep 3, 2026
Sale
$61.7520,000$1.2M328,436
TXG
STUELPNAGEL JOHN R—Sep 3, 2026
Proposed Sale
$61.7520,000$1.2M—
TXG
John R StuelpnagelDirectorAug 11, 2026
Sale
$57.7520,000$1.2M348,436
TXG
STUELPNAGEL JOHN R—Aug 11, 2026
Proposed Sale
$57.7520,000$1.2M—
—
STUELPNAGEL JOHN R—Aug 11, 2026
Proposed Sale
$57.7520,000$1.2M—